Insider filing · TRVI
Farrell Simon
Chief Commercial Officer
profile →
Trevi Therapeutics, Inc.
TRVI · Healthcare · 2 filings in 24 months
ticker →
Farrell Simon sold $518K of Trevi Therapeutics (TRVI)
Executed Mar 10 2025, disclosed Mar 12 2025, 2 days later.
Value, as filed
$518K
76,963 sh × $6.73
Executed
Mar 10 2025
the trade date, as filed
Disclosed
Mar 12 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
FSFarrell Simon (Chief Commercial Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Trevi Therapeutics, Inc. (TRVI). The largest single filing was $518K of TRVI (76,963 sh × $6.73, as filed), executed Mar 10 2025.
The name
TRVIHealthcare · Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes investigational therapy for the treatment…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→